Floatz logo

20 assets in Liposarcoma

Therapeutic assets addressing Liposarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fulvestrant
Liposarcoma
PfizerP2B (60)
Atirmociclib
Liposarcoma
PfizerP2CCC (53)
Enzalutamide
Liposarcoma
PfizerP2CCC (53)
Letrozole
Liposarcoma
PfizerP2CCC (53)
Midazolam
Liposarcoma
PfizerP2CCC (53)
Apg 115
Liposarcoma
Ascentage Pharma Group Inc.P1/2CC (47)
Docetaxel
Liposarcoma
OncoResponse, Inc.P1/2CC (47)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Liposarcoma
OncoResponse, Inc.P1/2CC (47)
Irinotecan
Liposarcoma
Milton S. Hershey Medical CenterP1/2CC (47)
Silmitasertib
Liposarcoma
Milton S. Hershey Medical CenterP1/2CC (47)
Toripalimab
Liposarcoma
Ascentage Pharma Group Inc.P1/2CC (47)
(+)-Vincristine
Liposarcoma
Milton S. Hershey Medical CenterP1/2CC (47)
Zovostotug
Liposarcoma
OncoResponse, Inc.P1/2CC (47)
21.15.gpc3-car t cells
Liposarcoma
Baylor College of MedicineP1CC (43)
Care T Cells
Liposarcoma
Baylor College of MedicineP1CC (43)
Catch T Cells
Liposarcoma
Baylor College of MedicineP1CC (43)
Eribulin Monomethanesulfonate
Liposarcoma
OHSU Knight Cancer InstituteP1CC (43)
nm32-2668
Liposarcoma
Numab Therapeutics AGP1CC (43)
pf-07224826
Liposarcoma
PfizerP1CC (43)
Sc-Car.Gpc3Xil15.21 Car T Cells
Liposarcoma
Seattle Children's HospitalP1CC (43)